FIRST CITIZENS BANK & TRUST CO - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 300 filers reported holding HAEMONETICS CORP in Q4 2019. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
FIRST CITIZENS BANK & TRUST CO ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2021$299,000
+30.6%
2,694
+39.8%
0.01%
+16.7%
Q4 2020$229,000
+6.0%
1,927
+12.6%
0.01%0.0%
Q4 2019$216,0000.0%1,7110.0%0.01%
-53.8%
Q3 2019$216,000
-43.3%
1,711
-46.0%
0.03%
-38.1%
Q2 2019$381,000
+38.0%
3,170
+0.3%
0.04%
+35.5%
Q1 2019$276,000
+20.0%
3,160
+37.7%
0.03%
+10.7%
Q4 2018$230,0002,2950.03%
Other shareholders
HAEMONETICS CORP shareholders Q4 2019
NameSharesValueWeighting ↓
Nitorum Capital, L.P. 413,122$16,608,0004.78%
Altalis Capital Management LLC 88,055$3,540,0003.97%
RUTABAGA CAPITAL MANAGEMENT LLC/MA 513,619$20,647,0003.54%
Black Creek Investment Management Inc. 1,118,613$44,968,0003.46%
HealthCor Management, L.P. 1,150,000$46,230,0002.61%
Van Berkom & Associates Inc. 1,136,971$45,706,0001.83%
AMERICAN CAPITAL MANAGEMENT INC 567,896$22,829,0001.77%
FULLER & THALER ASSET MANAGEMENT, INC. 2,062,539$82,914,0001.25%
Legato Capital Management LLC 1,336$53,707,0000.97%
HEARTLAND ADVISORS INC 351,314$14,123,0000.78%
View complete list of HAEMONETICS CORP shareholders